| Case |
Age/gender |
Clinical features |
diagnosis Associated |
Cytogenetics |
Outcomes |
Reference |
| 1 |
20/female |
Left maxillary and sphenoid sinus mass |
Isolated MS |
t(19:1) |
Chemotherapy then AHSCT; CR at 18 months |
Prades et al. [10] |
| 2 |
72/ female |
Right maxillary and ethmoidal sinusitis |
AML (M0), 1 year earlier |
Not reported |
Hydroxycarbamide and surgicaldebridment |
Ferrl et al. [11] |
| 3 |
63/male |
Right maxillary sinusitis |
Synchronous MDS |
Normal |
Died of systemic infection 2 years after the first symptoms |
Jo et al. [12] |
| 4 |
37/male |
Nasal cavity mass |
AML(M3), 3 years earlier, |
Normal |
Chemotherapy and radiotherapy 20Gy, died 35 months later after MS diagnosed |
Lan et al. [13] |
| 5 |
56/female |
Left maxillary sinus |
Isolated MS |
Not reported |
chemotherapy; CR at 4 months |
Mei et al. [14] |
| 6 |
73/male |
Left ethmoid sinus with
intracranial invasion; acute
fulminant invasive fungal
sinusitis |
AML (M6), 1
year earlier |
Normal |
Endoscopic debridement followed by radiotherapy, died 18 moth after
diagnosis of AML |
Kuo et al. [15] |
| 7 |
35/male |
Left maxillary sinusitis |
Isolated MS |
Normal |
Surgical biopsy and chemotherapy, died 28 months later after MS diagnosed |
Present
case |
Abbreviations: AHSCT, allogeneic hematopoietic stem cell transplant; AML, acute myeloid leukemia; CR, complete remission; MS, myeloid sarcoma; MDS, myelodysplastic
syndrome